Global Assisted Reproductive Technology (ART) Market Size, Share, Forecast Report, 2020-2027
The reproductive technology such as fertility medication, in vitro fertilization and surrogacy used to treat infertility among the women, is termed as assisted reproductive technology. The causes of infertility in women may be ovulation disorders, uterine or cervical abnormalities, fallopian tube damage or blockage, endometriosis, cancer and others. It may also be caused due to lifestyle factors like smoking tobacco or marijuana, alcohol consumption, overweight, lack of physical inactivity. Global assisted reproductive technology (ART) market is expected to grow at a CAGR of ~10% over the forecast period
The assisted reproductive technology market is expected to witness a tremendous growth owing to the rising prevalence of infertility. Other key factors such as the growing obesity among women, increase in ovulation disorders, change to sedentary lifestyle, growing consumption of unhealthy diet, increasing occurrence of Polycystic Ovarian Syndrome (PCOS), and increasing prevalence ovarian and endometrial cancer, increase in smoking and alcohol consumption are contributing towards the growth of the market. According to the Office on Women's Health 2012, around 6.1 million women of age 15-44 years in the US are unable to conceive. Such a high incidence of infertility is expected to drive the market growth during the forecast period.
However, factors such as lower success rate, the high cost of assisted reproductive technology procedures, expensive treatments, raising ethical issues, chances of birth defects, the risk of prematurity and low birth weight in newborn and side effects associated with hysterectomy procedures are expected to restrict the market growth during the forecast period.
Segmentation
Global Assisted Reproductive Technology (ART) Market Report, by Diagnosis (Ovulation Testing, Hysterosalpingography), Type (Ovulation Induction, Artificial Insemination, Surrogacy), End-User (Hospitals & Clinics, IVF Center) – Global Forecast Till 2023Global Assisted Reproductive Technology (ART) Market Report, by Diagnosis (Ovulation Testing, Hysterosalpingography), Type (Ovulation Induction, Artificial Insemination, Surrogacy), End-User (Hospitals & Clinics, IVF Center) – Global Forecast Till 2023
On the basis of region, the global assisted reproductive technology market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Key players
Some of the key players in the global assisted reproductive technology (ART) market are Cosmos Biomedical Limited, California Cryobank, Bloom IVF Centre, Cryolab Ltd., Parallabs, OvaScience, Anecova, Origio, Microm Ltd., Merck KGaA, Cooper Surgical, Inc, Ferring Pharmaceuticals, European Sperm Bank, Irvine Scientific and Hamilton Throne Ltd.
Market Segmentation
Global Assisted Reproductive Technology (ART) Market, by Diagnosis
Global Assisted Reproductive Technology (ART) Market, by Type
Global Assisted Reproductive Technology (ART) market, by End-User
Global Assisted Reproductive Technology Market, by Region
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers